Skip to main content
Alamar Biosciences, Inc. logo

Alamar Biosciences, Inc. — Investor Relations & Filings

Ticker · ALMR ISIN · US0109111056 Professional, scientific and technical activities
Filings indexed 19 across all filing types
Latest filing 2026-05-08 Interim / Quarterly Rep…
Country US United States of America
Listing ALMR

About Alamar Biosciences, Inc.

https://alamarbio.com/

Alamar Biosciences, Inc. is a commercial-stage proteomics company focused on powering precision proteomics for the earliest detection of disease. It develops and commercializes an automated, high-throughput, ultra-high sensitivity platform, including ARGO™ and NULISA™ technologies. This platform redefines protein biomarker detection by enabling the discovery of novel plasma biomarkers, even from low-volume specimens, that are often invisible with conventional immunoassays. The technology supports groundbreaking insights in biomarker discovery, drug development, and disease research, expanding applications across various conditions like Alzheimer's, TBI, and stroke, from pediatric to geriatric care.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report
2026-05-08 English
8-K
Regulatory Filings
2026-05-08 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-23 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-23 English
Regulatory Filings 2026
Regulatory Filings
2026-04-21 English
S-8
Registration Form
2026-04-20 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.